- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1476-5594
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancer therapeutic targeting using mutant–p53-specific siRNAs ; day:14 ; month:1 ; year:2019 ; pages:1-13
Oncogene ; (14.1.2019), 1-13
- Urheber
-
Ubby, Ifeoma
Krueger, Christian
Rosato, Roberto
Qian, Wei
Chang, Jenny
Sabapathy, Kanaga
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41388-018-0652-y
- URN
-
urn:nbn:de:101:1-2019022000391285100766
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ubby, Ifeoma
- Krueger, Christian
- Rosato, Roberto
- Qian, Wei
- Chang, Jenny
- Sabapathy, Kanaga
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Therapeutic opportunities for targeting microRNAs in cancer
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
Therapeutic targeting of microRNAs in the tumor microenvironment
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Therapeutic opportunities for targeting microRNAs in cancer
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond
Therapeutic targeting of microRNAs in the tumor microenvironment
Therapeutic targeting of BRCA1 and TP53 mutant breast cancer through mutant p53 reactivation
Targeting mutant p53 in cancer: the latest insights
Exploring mutant p53 targeting strategies for cancer therapy
Targeting mutant p53 for cancer therapy: direct and indirect strategies
Mutant p53 in cancer: from molecular mechanism to therapeutic modulation
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutant
APR-246 reactivates mutant p53 by targeting cysteines 124 and 277
New therapeutic strategies to treat human cancers expressing mutant p53 proteins
Therapeutic opportunities for targeting microRNAs in cancer
Targeting mutant p53 in spontaneous cancer by T cell receptor gene therapy
Targeting mutant p53: a key player in breast cancer pathogenesis and beyond